Doing Science in an Emergency : Challenging Clinical Trial Standards and Producing Care
Résumé
In 2014–15, an unprecedented Ebola outbreak in West Africa arrived in a world with no effective therapies or approved vaccines. Weak health systems and a delayed international response – with the exception of the early intervention of Médecins Sans Frontières (MSF) – were primarily to blame for a situation that spiralled out of control. Clinical trials of experimental Ebola interventions became a key component of the global response [...].